Joshua W Morse

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 10

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Drug Administration

Top Venues

Antibody therapeutics

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua W Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G Daver, Courtney D D DiNardo, Ningyan Zhang, Zhiqiang An
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert opinion on investigational drugs 32 (2) (2023)
Joshua W Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G Daver, Courtney D D DiNardo, Ningyan Zhang, Zhiqiang An
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert opinion on investigational drugs 32 (2) (2023)
Joshua W Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G Daver, Courtney D D DiNardo, Ningyan Zhang, Zhiqiang An
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert opinion on investigational drugs 32 (2) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G Daver, Courtney D D DiNardo, Ningyan Zhang, Zhiqiang An
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert opinion on investigational drugs 32 (2) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Chengcheng Zhang, Ningyan Zhang, Zhiqiang An
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. Antibody therapeutics 7 (1) (2023)
Joshua W Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G Daver, Courtney D D DiNardo, Ningyan Zhang, Zhiqiang An
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert opinion on investigational drugs (2023)